| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -563.9% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 17.3 | n/a |
| Pr/Book | 11.4 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 90.4% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-21 | 0.69 | (1.85) | (1.17)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-22 | 0.05 | (5.63) | 5.44p | 3.2 | n/a | n/a | n/a | 0.0% |
| 30-Jun-23 | 0.06 | (5.98) | (5.44)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-24 | 0.50 | (7.75) | (4.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-25 | 0.95 | (5.43) | (0.89)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Welsh hospitals extend routine MT-RNR1 testing | 10-Sep-2026 | 07:00 | RNS |
| Director/PDMR Notification | 01-Sep-2026 | 07:00 | RNS |
| Board Appointments | 21-Aug-2026 | 07:00 | RNS |
| Director dealings: Genedrive CEO raises stake | 01-Sep-2026 | ShareCast |
| Genedrive collects £0.76m R&D tax credit | 05-Jun-2026 | ShareCast |
| Sussex NHS trust moves to routine use of Genedri... | 05-May-2026 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1.20p |
| Change Today | 0.025p |
| % Change | 2.13 % |
| 52 Week High | 1.40 |
| 52 Week Low | 0.23 |
| Volume | 2,145,324 |
| Shares Issued | 1,605.57m |
| Market Cap | £19.27m |
| RiskGrade | 747 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:14 | 752,539 @ 1.17p |
| 15:01 | 932 @ 1.16p |
| 14:35 | 5,699 @ 1.20p |
| 14:35 | 11 @ 1.20p |
| 14:35 | 11 @ 1.15p |
| CFO | Russell Shaw |
| CEO | Gino Miele |
| Chair | Graham Cole CBE |
You are here: research